Compare LEXX & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | BLIN |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 9.0M |
| IPO Year | 2011 | 2018 |
| Metric | LEXX | BLIN |
|---|---|---|
| Price | $4.53 | $0.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.2K | ★ 41.1K |
| Earning Date | 11-27-2026 | 12-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $705,923.00 | ★ $13,568,000.00 |
| Revenue This Year | N/A | $20.26 |
| Revenue Next Year | $6,915.00 | $21.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.35 | $0.62 |
| 52 Week High | $21.60 | $1.42 |
| Indicator | LEXX | BLIN |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 35.40 |
| Support Level | $2.67 | N/A |
| Resistance Level | $10.26 | $1.05 |
| Average True Range (ATR) | 0.41 | 0.06 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 74.74 | 0.53 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.